Takashi M, Sakata T, Nakano Y, Takagi Y, Yamada Y, Hibi H, Miyake K, Shirai T
Department of Urology, Nagoya University School of Medicine, Japan.
Cancer Lett. 1994 Dec 9;87(2):151-7. doi: 10.1016/0304-3835(94)90216-x.
The present study was conducted to clarify the effects of N-ethyl-N-hydroxyethylnitrosamine (EHEN) and uracil in combination on renal carcinogenesis in female F344 rats. Group 1 animals (n = 30) received a 3-week simultaneous administration of 0.05% EHEN and 3% uracil, and group 2 (n = 26) 0.05% EHEN with a lower 1.5% dose of uracil. Group 3 (n = 30) was treated with 0.05% EHEN alone and group 4 (n = 28) received only 3% uracil for 3 weeks. In all the above four groups, the rats were given basal diet and water without chemical addition for a 48-week period after the 3-week treatment period. Group 5 (n = 33) received no chemicals for the entire 52 weeks. At the end of week 52, renal adenocarcinomas were found in 53%, 31% and 13% of the rats in groups 1, 2, and 3, respectively. The present study thus demonstrated that simultaneous administration of uracil enhances the occurrence of EHEN-induced renal adenocarcinomas in rats.
本研究旨在阐明N-乙基-N-羟乙基亚硝胺(EHEN)与尿嘧啶联合使用对雌性F344大鼠肾癌发生的影响。第1组动物(n = 30)接受为期3周的0.05% EHEN和3%尿嘧啶同时给药,第2组(n = 26)接受0.05% EHEN与较低剂量1.5%尿嘧啶的给药。第3组(n = 30)仅用0.05% EHEN治疗,第4组(n = 28)仅接受3%尿嘧啶治疗3周。在上述四组中,大鼠在3周治疗期后48周内给予无化学添加的基础饮食和水。第5组(n = 33)在整个52周内未接受任何化学物质。在第52周结束时,第1、2和3组大鼠中分别有53%、31%和13%发现肾腺癌。因此,本研究表明,同时给予尿嘧啶会增加大鼠中EHEN诱导的肾腺癌的发生率。